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Background: Ipsilateral asymptomatic renal stone associated with symptomatic ureteral stone is not a rare event,
and the recommended treatment policy was not declared clearly. This study was conducted to compare the
outcomes of simultaneous retrograde intrarenal surgery (RIRS) and ureteroscopy to ureteroscopy alone for this
clinical event.
Methods: 415 patients with symptomatic ureteral stone and ipsilateral asymptomatic renal stones were reviewed
to obtain two match groups, who were treating with simultaneous modality (group A, N = 72), or ureteroscopy
alone (group B, N = 72). Matching criteria were ureteral and renal stone side, duration and location, the presence of
pre-stented. Perioperative and postoperative characteristics were compared between the two groups.
Results: Mean stone burdens were similar between group A and B. Mean operative duration for group A and B
were 72.4 ± 21.3 and 36.4 ± 10.2 min, respectively (P < 0.001). Mean hospital duration was 6.4 ± 2.9 and 5.3 ± 2.1 days
in group A and B, respectively (P = 0.521). Ureteral SFR was 100% in each group. Renal SFR for RIRS was 86.1%.
Complication rates in group A were higher (22.2% vs 13.9%), but the differences were not statistically significant
(P = 0.358). In group A, complications were significantly less in pre-stented patients (3/25 vs 5/11, P = 0.04). Auxiliary
treatment rate was significant higher in group B (69.4% vs 5.6%, P < 0.001) during follow-up (mean >18 months).
Conclusions: Simultaneous RIRS for ipsilateral asymptomatic renal stones in patients with ureteroscopic
symptomatic ureteral stone removal can be performed safely and effectively. It promises a high SFR with lower
auxiliary treatment rate, and does not lengthen hospital duration and increase complications.
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Asymptomatic renal stones are common in urological pa-
tients. They would be symptomatic without a complete re-
trieval at a certain time and required surgical treatment
[1]. Although the current recommended method is active
surveillance with an option for 2–3 years in EUA guide-
lines, it will be associated with a higher risk of surgical
intervention [2,3]. Ipsilateral asymptomatic renal stone* Correspondence: dehuilai@hotmail.com
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unless otherwise stated.associated with symptomatic ureteral stone is not a rare
event, and the recommended treatment policy was not
declared clearly in any guidelines, especially in patients
who had already removed symptomatic ureteral stone by
ureteroscopy.
Retrograde intrarenal surgery (RIRS) is rapidly popular,
benefited from the advance in flexible ureteroscopic in-
strumentation and holmium laser lithotripsy. It had been
reported as an effective and definitive therapeutic option
for patients with small to mid-size renal stones [4-6]. It
is also recommended in some endourological centers for
its high stone free rate (SFR) and low complications,
when comparing with shock wave lithotripsy (SWL) andis an Open Access article distributed under the terms of the Creative Commons
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stones in size of <2 cm [4,7-9]. Although a high success
rate has been showed independently for endoscopic treat-
ment of ureteral and renal stones, there are few reports in
the literature on simultaneous RIRS for asymptomatic
renal stones in patients with ipsilateral ureteroscopic
symptomatic ureteral stone removal.
The aim of this study was to evaluate the effectiveness
and associated complications of this policy.
Methods
We obtained approval for this study from the ethics
committee of the fifth affiliated hospital of Guangzhou
Medical University. Written informed consent was ob-
tained from all the participants. This study was designed
as a retrospective controlled study, approved by our hos-
pital review board. The computerized files of 415 pa-
tients with ipsilateral symptomatic ureteral stone and
asymptomatic renal stones between March 2009 and July
2013 were reviewed and a database was constructed. 72
patients who underwent simultaneous RIRS for ipsilat-
eral asymptomatic renal stones after ureteroscopic
symptomatic ureteral stone removalwas defined as group
A. The matched group was 72 patients, who underwent
ureteroscopic laser lithotripsy (URL) for the symptom-
atic ureteral stone alone (group B). Matching criteria
were stone side, burden and location, as well as the pres-
ence of a pre-placed D-J stent.
Patients with congenital renal anomalies, pelvi-ureteral
junction obstruction, ureteral strictures, previous SWL
treatment, and urinary tract infection were excluded. Ur-
eteral and renal stone side and location were assessed
preoperatively by noncontrast spiral CT scanning. Stone
burden was defined as the surface area and calculated
according to the European Association of Urology guide-
lines. Preoperative laboratory tests included blood and
urinary routine test, serum creatinine estimation, and
prothrombin concentration.
Surgical procedure
Prophlactic parenteral antibiotics were administrated in
all patients. Patients were placed in the lithotomy pos-
ition under continual epidural anesthesia. After retro-
grade pyelography, a 0.035 inch guidewire was placed in
the upper tract. Ureter stones were treated using 8.0/9.8
French ureteroscope (Richard Wolf ). Large stones were
fragmented with holmium laser and the fragments were
removed with the stone basket or grasping devices. After
the ureteral stone was completely removed, a 12/14 F
ureteral access sheath (UAS) (COOK) was placed with
appropriate length in the patients who will undergo
RIRS. The flexible ureteroscope (7.5Fr Karl Storz Flex-X,
or 6/9.9Fr Richard Wolf Cobra) was inserted through
the guidewire to the renal pelvis. Complete inspection ofthe entire collecting system was performed and small
stones were removed by nitinol basket. Large stones were
fragmented with holmium laser. Adequate stone fragmen-
tion was considered when fragments could remove by the
stone basket or smaller than 2 mm in diameter. At the
end of the procedure, the entire collecting system was
inspected for the residual stones under the fluoroscopic
guidance and a D-J stent was left for 4 weeks.
One month after procedure, all patients were assessed
by noncontrast spiral CT to confirm the SFR. Complete
stone-free was defined as the absence of any fragments.
A visual analogue pain scale (VAS) was used to quantify
the degree of pain. Preoperative and postoperative char-
acteristics, complication rate, hemoglobin drop, hospital
duration, SFR, auxiliary treatment rate (ATR), medical
cost were compared between two groups. Auxiliary
treatments were defined as the treatment for managing
the residual renal stone or sever complication. Auxiliary
procedure was defined as using surgical methods in the
treatment during follow-up.
After the first follow-up evaluation, patients returned
for an assessment with urinalysis, KUB or urinary ultra-
sound every 3 months during the first year and every
6 months thereafter.
Statistical analysis was done using SPSS 17.0® for
Windows®. Continuous variables were compared with stu-
dent t test and Wilcoxon test, and Univariable analysis was
conducted using the Pearsonχ2 statistic or Fisher’s exact
test for categorical data. Differences resulting in p < 0.05
were considered significant.
Results
Patients’ demographic and preoperative characteristics
were summarized in Table 1. There were no significant
differences between two modalities. Perioperative and
Postoperative characteristics were compared in Table 2.
Mean operative duration for group A and B were 72.4 ±
21.3 (range 42.5–100) and 36.4 ± 10.2 (range 24–50)
min, respectively (P < 0.001). Mean fluoroscopy time was
significantly longer in group A (P < 0.001). Mean drop in
the postoperative hemoglobin level was 0.5 ± 0.21 (range
0.1–0.7) g/dL in group A, which was found to be statisti-
cally significant (P < 0.001) compared with the corre-
sponding decrease (0.2 ± 0.11, range 0.1–0.4 g/dL) in
group B. However, no blood transfusion was required in
both groups. VAS was higher in group A at postoperative
6 h, 12 h and 24 h, but the difference was not statistically
significant at postoperative 24 h (P = 0.477). Mean hospital
duration was 6.4 ± 2.9 days (range 3–12) in group A, and
5.3 ± 2.1 days (range 2–12) in group B (P = 0.521).
Complication rates in group A were higher (22.2% vs
13.9%), but the differences were not statistically signifi-
cant (P = 0.358). Four patients in each group were ad-
ministrated by oral analgesics for post-operative pain
Table 1 Demographic data of patient
Group A (URL + RIRS) Group B (URL alone)
(URL alone)
Variable 72 patients 72 patients P
Age, year, mean (SD), range 48.2 (11.4),19–65 50.4 (13.2),22–71 0.296
Gender, no. (%) 0.468
Males 42 (58.3) 48 (66.7)
Females 30 (41.7) 24 (33.3)
BMI, kg/m2, mean (SD), range 22.98 (3.51),19–32 25.32 (5.12),20–31 0.084
Stone side, no. (%) 0.481
Left 30 (41.7) 36 (50)
Right 42 (58.3) 36 (50)
Grade of hydronephrosis, no. (%) 0.659
None 8 (11.1) 10 (13.9)
Mild 46 (63.9) 38 (52.8)
Moderate 18 (25) 24 (33.3)
Ureteral stone location, no. (%) 0.405
proximal 20 (27.8) 24 (33.3)
middle 8 (11.1) 12 (16.7)
distal 44 (61.1) 36 (50)
Ureteral stone burden, mm2, mean (SD), range 67.4 (27.2),40.2–110.3 71.3 (31),39.2–102.3 0.884
Renal stone location 0.981
Upper pole 22 (30.6) 20 (27.8)
Middle pole 20 (27.8) 24 (33.3)
Lower pole 30 (41.6) 28 (38.9)
Renal stone burden, mm2, mean (SD), range 110.1 (42.2),68.3–170.1 124.5 (36.7),75.2–174.3 0.589
Pre-procedural placement of D-J stent, no. (%) 50 (69.5) 52 (72.2) 0.802
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in group A was treated by oral antiemetic. Transient post-
operative fever was developed in four patients in each
group and could be successfully treated with antibiotics and
antipyretics (Clavien). Of group A and B, four and two, re-
spectively, had minor ureteral perforations (Clavien a).
They were successfully treated by D-J stent for 8 weeks
and did not have any subsequent sequelae at follow-up.
In group A, complications were significantly less in pa-
tients with pre-procedural D-J stent placement (3/25 vs
5/11, P = 0.04). Also, ureteral perforation was only
encountered in patients without pre-procedural D-J
placement.
One-month ureteral SFR was 100% in each group. In
group A, one-month renal SFR was 86.1%. Eight failures
of RIRS were due to impossible to reach the calyx contain-
ing stone. Residual fragments were seen in two patients,
which were passed spontaneously during follow-up. Statis-
tically significant was not found in stone composition be-
tween group A and B.
Follow-up data was recorded in all patients (Table 3).
Mean follow-up time for all patients was 18.6 ± 9.6 months
(range 12–36). The ATR was significant higher in group B(69.4% vs 5.6%, p < 0.001). In group A, two patients under-
went PCNL for renal stone, while 62 auxiliary procedures
were performed in 46 patients in group B, including URL
(n = 10), RIRS (n = 22), ESWL (n = 26), PCNL (n = 4). Of
46 patients, Four had obstructing steinstrasse after ESWL
were treated by URL, ten underwent RIRS because of sig-
nificant residual stone after ESWL and two underwent
PCNL for the renal stone due to failure in RIRS. There-
fore, mean number of procedures per patient was signifi-
cantly higher in group B (1.86 vs 1.03, p < 0.001). But
mean medical cost per patient was still higher in group A
(16431.2 ± 3425.3 vs 13125.1 ± 2165.4 RMB, P < 0.001).
Discussion
Asymptomatic renal stone associated with ipsilateral
symptomatic ureteral stone is not a rare event [10,11].
URL has equivalent or superior results comparing with
ESWL in treating symptomatic ureteral stone. [12]
When encountering a coexisted ipsilateral asymptomatic
renal stone, no established guidelines are available. Ac-
tive observation, ESWL, PCNL as well as RIRS should
be discussed. Previous research had showed that active
observation will be associated with a higher risk of
Table 2 Perioperative and postoperative characteristics of patients
Group A Group B
(URL + RIRS) (URL alone)
Variable 72 patients 72 patients P
Operative duration, mean (SD), range (min) 72.4 (21.3),42.5–100 36.4 (10.2),24–50 <0.001
Haemoglobin drop (g/dL), mean (SD) 0.5 (0.21),0.1–0.7 0.2 (0.11),0.1–0.4 <0.001
Hospital duration, mean, (SD), range (days) 6.4 (2.9),3–12 5.3 (2.1),2–12 0.521
Complication rate, no. (%) 8 (22.2) 5 (13.9) 0.358
Modified Clavien classification
GradeI 8 (11.1) 4 (5.6)
Grade II 4 (5.6) 4 (5.6)
Grade IIIa 4 (5.6) 2 (2.8)
Pain visual analogue score (1 – 10), mean, (SD), range
At 6 h 4.3 (1.3),4–7 3.1 (1.1),2–6 <0.001
At 12 h 2.8 (0.9),2–5 2.1 (0.7),1–4 <0.001
At 24 h 2.0 (0.3),1–4 1.8 (0.1),1–3 0.477
Ureteral stone free rate (U-SFR), no. (%) 72 (100) 72 (100) -
Renal stone free rate (R-SFR), no. (%) 62 (86.1) 0 (0) <0.001
Stone composition, no. (%) 0.872
Calcium oxalate 34 (47.2) 30 (41.7)
Calcium oxalate and phosphate 20 (27.8) 24 (33.3)
Uric acid 16 (22.2) 14 (19.4)
Struvite 2 (2.8) 4 (5.6)
Table 3 Follow-up data of patients
Group A Group B
(URL + RIRS) (URL alone)
Variable 72 patients 72 patients P
Follow-up, mean, (SD), range (months) 18.9 (10.2),14–32 18.5 (9.4),12–34 0.675
Auxiliary treatment rate, no. (%) 4 (5.6) 50 (69.4) <0.001
Cause of auxiliary treatment in follow-up, no. (%)
Renal colic 2 (2.8) 10 (13.9)
Repetatus urinary tract infection 0 6 (8.3)
Stone induced hematuria 2 (2.8) 10 (13.9)
Increase in creatinine levels 0 4 (5.6)
Patient’s desire (increased stone duration) 0 20 (27.8)
Medical expulsive treatment, no. (%) 2 (2.8) 4 (5.6) <0.001
Patients required auxiliary procedures, no (%). 2 (2.8) 46 (63.9) <0.001





Procedure per patient, mean, (SD), range 1.03 (0.17),1–2 1.86 (0.76),1–3 <0.001
Medical cost per patient, mean, (SD), range (RMB) 16431.2 (3425.3) 13125.1 (2165.4) <0.001
14985.3–21325.4 9105.1–15143.2
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often needed multiple sessions to achieve higher SFR
[13]. PCNL, a favoured treatment for stone >2 cm, is as-
sociated with higher potential risks, such as bleeding,
urosepsis, and urine leakage [2]. Recently, simultan-
eously RIRS becomes feasible in treating ipsilateral renal
stone and seems to be an attractive option. We compare
the outcomes of this simultaneous modality to URL
alone in this study.
Ureteral stone was completely removed in each group.
In simultaneous RIRS group, the overall renal SFR after
1 month was 86.1%, which was similar to that of previ-
ous reports. Goldberg H et al. showed that patients with
pre-procedural D-J stent can achieve a higher renal SFR
(93.3% VS 71%) [14]. However, the difference was not
found in this study. Inability to reach the lower pole
calyx may be the main reason of RIRS failure [15,16].
We observed that eight cases were due to this. Also, the
other predictive factor of renal SFR was stone size.
Grasso and Ficazzola reported that RIRS can achieved
an SFR of 82%, 71% and 65% with stone size of <1 cm,
1–2 cm and >2 cm, respectively [15]. RIRS may be re-
quired to clear a large stone by multiple procedures [17].
In our center, it is often performed for renal stone in size
of <2 cm, which can achieved a higher SFR in one ses-
sion. In this study, the simultaneous RIRS achieved
86.1% renal SFR for treating this size stone.
The other important results were lower ATR, while
complications were not significantly increased. The
causes of the higher ATR in URL alone group were often
stone induced (Table 3). In Streem’s and Glowacki’s
study, respectively, Patients with active observation,
more than 70% and 48.5% required treatment due to in-
creased stone duration or clinical symptomatic episode
in next 5 years [18,19]. Although our mean follow-up
period were >18 months, the ATR was 69.4% in URL
alone group comparing to only 5.6% in simultaneous
RIRS group. Few patients with residual stone may be
one of the reasons. And the other reason was that causes
of auxiliary treatment after RIRS were unexpected inci-
dents such as complications or flexible ureteroscope
damage, which is low in current reports Therefore, it is
important to emphasize the possibility of auxiliary treat-
ment in patients with URL alone is up to 70%, and with
simultaneous RIRS is only required in unpredictable
situation during preoperative conversation.
UAS is becoming increasingly popular worldwide be-
cause of facilitating the access, decreasing intrarenal
pressure and protecting the scope [20]. However, several
studies had shown that the over distention created by UAS
may induce ureteral ischemia and wall injuries [21]. In this
study, we found that ureteral perforations were developed
in two patients in simultaneous RIRS group, who were not
pre-stented. Traxer O and Thomas A reported that D-Jprestenting significantly decreases the incidence of severe
access sheath related injuries [22]. Moreover, overall com-
plications were significantly less in patients with pre-
procedural D-J stent (6/50 vs 10/22, P = 0.04). Thereby, it
is wisdom to place DJ stent pre-procedurally in patients
who were planned to undergo simultaneous RIRS.
Although RIRS had minimal invasive nature, the low
morbidity was probably due to greater expertise in high-
volume RIRS center. When a surgeon is still in his learn-
ing curve of RIRS, more attention should be paid in per-
forming simultaneous modality.
Beside the invasive nature of RIRS, another disadvan-
tage included the consumption of expensive instruments
such as fragile flexible ureteroscope, nitinol basket and
UAS. Large studies showed the need for repair flexible
ureteroscope after an average of 18 cases [23]. Obvi-
ously, the costs for RIRS are higher than URL. In our
study, although mean procedure per patient was signifi-
cantly more in URL alone group, the mean medical cost
per patient was still higher in simultaneous RIRS group
during follow-up (mean >18 months). Simultaneous mo-
dality does not appear to be cost effective. However, SH
Lee et al. reported that patients benefited from cost-
effectiveness when choosing RIRS simultaneously, with re-
spect to their health insurance system [24]. Rencently, re-
pair for a new generation flexible ureteroscopes was
needed after 20–22 procedures [25,26]. Moreover, flexible
ureteroscopes can have a significantly longer lifespan (10.6
vs 21.6 uses before damage), by following guidelines and
with training. [27]. Thus, we believed that the results may
be changed with the developments of instruments, tech-
niques and national health insurance system.
An interesting observation from study was that
47.8% patients in URL alone group underwent ESWL.
Despite higher retreatment rates, it remains a preferred
option because of non-invasive nature and high level
of acceptance by patients and doctors. Although Kee-
ley FX et al. demonstrated that ESWL for small asymp-
tomatic renal stones does not offer any advantage to
patients in terms of SFR comparing to observation
(28% vs 17%, P = 0.06) [1], we found it can partly elim-
inate apprehensiveness of patients, and can achieve a
higher SFR in upper pole renal stone. However, A pol-
icy of treating asymptomatic renal stones with ESWL
may be still associated with a high risk of requiring
invasive procedures > 50% patients were required add-
itional URL, RIRS or even PCNL for obstructing stein-
strasse and residual stone.
The main limitation of this study is its retrospective
design. Allocation to a treatment modality depended on
the surgeon’s preference. We tried to overcome this pos-
sible selection bias by comparing match groups of pa-
tients and stones. Another limitation was the small
number of patients and a single center study. Therefore,
Lai et al. BMC Urology  (2015) 15:22 Page 6 of 6a prospective randomized controlled study with a larger
sample of multiple centers with a long time follow-up is
needed.
Conclusions
Simultaneous RIRS for ipsilateral asymptomatic renal
stones in patients with ureteroscopic symptomatic ureteral
stone removal can be performed safely and effectively.
It promises a high SFR with lower auxiliary treatment
rate, and dose not lengthen hospital duration and in-
crease complications.
Pre-procedurally Placing DJ stent in patients planned
to undergo RIRS simultaneously may reduce the compli-
cation rate.
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